MPT (MPT)

Market Cap
P/E Ratio
Beta
Dividend Yield
Piotroski 4/9Beneish M -2.39 Clean

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics reveal a distressed operational profile characterized by significant value destruction, evidenced by an ROIC of 3.1% and a negative DuPont-decomposed ROE of -6.0%, driven primarily by a severe net margin contraction to -28.5%. While the gross margin remains robust at 96.2%, indicating strong pricing power or low cost of goods sold, this advantage is completely negated by operating inefficiencies resulting in minimal asset turnover of only 0.06x and negative bottom-line performance despite a moderate equity multiplier of 3.26x. The deteriorating financial health is further corroborated by a weak Piotroski F-Score of 4/9, suggesting limited fundamental improvements relative to the prior year, whereas the Beneish M-Score of -2.39 implies low probability of earnings manipulation but does not offset the genuine profitability crisis.

Valuation metrics reflect these underlying operational challenges through negative equity generation and declining revenue growth of -2.4% year-over-year. Without positive net income or meaningful cash flow to anchor a traditional discounted cash flow model, fair value assessments become highly speculative as implied growth rates are effectively non-existent in the current fiscal environment. The market appears to be pricing in continued stagnation rather than recovery potential, given that insider activity over the last 90 days remains neutral with zero net flow, signaling no immediate confidence shift from management or major stakeholders regarding the company's trajectory.

The risk/reward asymmetry is skewed heavily toward downside exposure due to the combination of negative returns on invested capital and shrinking top-line revenue. While the low Beneish score suggests financial statements may be reliable in their depiction of poor performance, the structural inability to convert assets into profit or generate shareholder value creates a precarious position for equity holders. Investors must weigh whether current market pricing adequately compensates for the high probability of further margin erosion and capital efficiency decline before any potential turnaround materializes.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
-2.39
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

96.3%
Gross Margin
-28.5%
Net Margin
3.1%
ROIC
-2.4%
Revenue Growth (YoY)
+88.5%
Earnings Growth (YoY)

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

-28.5%
Net Profit Margin
NI ÷ Revenue
×
0.06x
Asset Turnover
Revenue ÷ Assets
×
3.26x
Equity Multiplier
Assets ÷ Equity
=
-6.0%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

2.26x
Debt / Equity
1.51x
Current Ratio
10.5x
Net Debt / EBITDA
812.6M
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $-0.01
Act: $-0.20
-2467.4%
Q3
✗ Miss
Est: $0.02
Act: $-0.16
-1076.8%
Q2
✗ Miss
Est: $0.02
Act: $-0.13
-641.7%
Q1
✓ Beat
Est: $0.00
Act: $0.07
0.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

Forward P/E
PEG Ratio
Price/Book
Avg Volume
52W High
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$107M
Tracked Passive Exposure
4
ETFs Holding MPT
0.11%
Avg Weight in ETFs
$97B
Total ETF AUM

When investors buy or sell ETFs like SLYV or SPSM, the fund manager is mechanically forced to buy or sell MPT shares regardless of MPT's individual fundamentals. We estimate $107M of passive capital is structurally linked to MPT through 4 tracked ETFs. Passive flows have a limited but growing influence on MPT's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 4 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in MPT to visualize passive redemption contagion across ETFs and collateral stocks.

MPT Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
MPTEpicenterVNQETFSPSMETFSPTMETFVRTPXUnknownWELLLow RiskNVDALow RiskPLDMed RiskAAPLLow Risk
MPT Price Drop (%)0

If MPT (MPT) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Vanguard Real Estate II Index Fund Institutional Plus Shares (VRTPX) as the most exposed collateral stock, sharing 1 ETFs with MPT. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 4 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

MPT Ownership Dynamics

Ticker
MPT

Float lock-up computed from 4 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1276,558$5.04$385,852.32
2026-05-082,266$5.33$12,077.78
2026-05-0580,208$4.97$398,633.76
2026-05-0475,691$5.05$382,239.55
2026-05-0128,245$4.94$139,530.3
2026-04-3064,425$5.13$330,500.25
2026-04-29119,014$5.17$615,302.38
2026-04-242,626$5.21$13,681.46
2026-04-2348$5.17$248.16
2026-04-20642$5.23$3,357.66
2026-04-16150,009$5.00$750,045
2026-04-1514,918$5.01$74,739.18
2026-04-1411,596$4.94$57,284.24
2026-04-13170,227$4.94$840,921.38
2026-04-10113,455$4.83$547,987.65
2026-04-09420$4.75$1,995
2026-04-0819,759$4.67$92,274.53
2026-04-06138$4.63$638.94
2026-04-02157,359$4.64$730,145.76
2026-03-2787$4.67$406.29
2026-03-241,433$4.56$6,534.48
2026-03-2327,876$4.56$127,114.56
2026-03-2018,869$4.71$88,872.99
2026-03-19144,083$4.80$691,598.4
2026-03-1878,159$4.83$377,507.97
2026-03-17159,396$4.78$761,912.88
2026-03-16165,235$4.79$791,475.65
2026-03-13173,383$5.01$868,648.83
2026-03-12740,790$4.93$3.7M
2026-03-11135,706$5.36$727,384.16

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare MPT to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.